Physician profile
Yi Li
NPI 1881896132
$1,196.49
in general payments reported to CMS, 2019-2025
18 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $132 · 2021: $120 · 2023: $277 · 2024: $67.30 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.72 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $234.85 | 2023-2025 | Veozah |
| Abbvie INC. | $181.83 | 2019-2025 | |
| Sage Therapeutics, LLC | $113.07 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $112.92 | 2019-2025 | |
| Evofem Biosciences, INC. | $94.39 | 2020-2025 | Phexxi, Solosec, Phexx |
| Allergan, INC. | $69.53 | 2019 | |
| Mylan Pharmaceuticals INC. | $56.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $52.77 | 2019-2020 | |
| Pfizer INC. | $50.27 | 2023-2025 | |
| Therapeuticsmd, INC. | $37.95 | 2020 | |
| Coopersurgical, INC. | $34.99 | 2019-2024 | Paragard T 380a |
| Exeltis, USA INC. | $29.81 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $27.25 | 2024 | Aptima |
| Dynavax Technologies Corporation | $25.09 | 2025 | Heplisav-B |
| Supernus Pharmaceuticals, INC. | $21.65 | 2025 | Qelbree |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.47 | 2023 | Arista Ah Flexitip |
| Millicent US INC | $18.88 | 2019 | |
| Medtronic, INC. | $14.54 | 2023 | Closurefast |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.